Latest Health News

Flagship Minerals has exited its lithium project in Chile amid market oversupply, redirecting resources to its Pantanillo Gold Project with a significant 1.05 million ounce gold resource estimate.

Collins Foods reported a record $1.52 billion revenue for FY25 with flat EBITDA despite tough market conditions, while signaling optimism for low to mid-teens NPAT growth in FY26.

Xstate Resources has appointed joint lead managers for a $2-3 million capital raise aimed at re-compliance with ASX listing rules and trading reinstatement. The company also plans a key acquisition pending shareholder approval.

Microba Life Sciences has raised $14.5 million to accelerate clinical adoption of its microbiome testing products, while narrowing its FY25 revenue guidance and signing a strategic UK laboratory agreement.

Eden Innovations is progressing toward the sale of its 65-acre industrial property in Augusta, Georgia, with settlement expected in August pending final permits. The deal will significantly reduce the company’s debt and interest expenses.

GPT Group has announced an estimated distribution of 12.0 cents per stapled security for the first half of 2025, setting the stage ahead of its interim results release in August.

US Masters Residential Property Group has repatriated US$40 million from its USA Fund back to its main Australian fund, hinting at upcoming capital management decisions.

Zoono Group Limited has announced a pro rata non-renounceable rights issue aiming to raise approximately $1.78 million at $0.035 per share. The capital raise will support shelf-life extension projects, repay related party debt, and bolster working capital.

RLF AgTech has resolved a legal dispute over a consultancy agreement, clearing the way for renewed focus on expanding its crop nutrition business domestically and internationally.

Aspen Group has declared a final distribution of 5.00 cents per security for FY25, lifting the total annual payout by 18% compared to last year. The company maintains its suspension of the Distribution Reinvestment Plan ahead of full year results.

Proteomics International has launched PromarkerD, a pioneering blood test that predicts diabetic kidney disease years before symptoms, marking its entry into the vast US healthcare market.

Macmahon Holdings has locked in a new $550 million syndicated debt facility, extending maturity to 2029 with improved terms and robust bank backing. This refinancing positions the company for strategic growth while maintaining a conservative liquidity stance.